1. The rs10993994 functional polymorphism in the MSMB gene promoter increase the risk of prostate cancer in an Iranian population
   Ghazaleh Shahkar et al, 2017, Meta Gene CrossRef
2. TP53 gene Arg72Pro polymorphism and male infertility risk: A meta-analysis
   Zheng-Ju Ren et al, 2018, Andrologia CrossRef
3. 4‐bp insertion/deletion (rs3783553) polymorphism within the 3′UTR of IL1A contributes to the risk of prostate cancer in a sample of Iranian population
   Mohammad Hashemi et al, 2018, Journal of Cellular Biochemistry CrossRef
4. Analysis of 12 variants in the development of gastric and colorectal cancers
   Giovanna C Cavalcante et al, 2017, World Journal of Gastroenterology CrossRef
5. The 40bp Indel Polymorphism rs150550023 in the MDM2 Promoter is Associated with Intriguing Shifts in Gene Expression in the p53-MDM2 Regulatory Hub
   Heidi Miedl et al, 2020, Cancers CrossRef
6. Genetic and molecular determinants of prostate cancer among Iranian patients: An update
   Majid Ghayour-Mobarhan et al, 2020, Critical Reviews in Clinical Laboratory Sciences CrossRef
7. Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies
   Zachary S. Dovey et al, 2021, Cancer Reports CrossRef
8. Association between TP53 gene codon72 polymorphism and prostate cancer risk
   Pei-Zhen Han et al, 2019, Medicine CrossRef
9. Data-driven translational prostate cancer research: from biomarker discovery to clinical decision
   Yuxin Lin et al, 2020, Journal of Translational Medicine CrossRef
10. Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis
    Brehima Diakite et al, 2020, BMC Medical Genetics CrossRef
11. Molecular imaging and treatment of PSMA-positive prostate cancer with 99mTc radiolabeled aptamer-siRNA chimeras
    Yuying Jiao et al, 2022, Nuclear Medicine and Biology CrossRef
12. Association of Murine Double Minute 2 polymorphisms with gastric cancer: A systematic review with meta‑analysis
    Mafalda Timóteo et al, 2021, Biomedical Reports CrossRef
13. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study
    Rostam Maruei‐Milan et al, 2019, Journal of Cellular Physiology CrossRef
14. MiR‐206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11
    Yao Wang et al, 2018, The Prostate CrossRef
15. Lack of relationship between PTEN 32-bp and TP53 16-bp Ins/Del polymorphisms and chronic hepatitis B virus infection
    Ebrahim Eskandari et al, 2017, VirusDisease CrossRef
16. Association between genetic polymorphisms of long non‑coding RNA PRNCR1 and prostate cancer risk in a sample of the Iranian population
    Hedieh Sattarifard et al, 2017, Molecular and Clinical Oncology CrossRef